Caitríona Grönberg

Caitríona Grönberg has been working since 2010, starting as a PhD student at Lund University's Cardiovascular Research Unit. Caitríona then moved to a postdoc role in Jens Lagerstedt's research group at Experimental Medical Sciences, BMC, Lund University in 2016. Her project aimed to delineate the potential role of ApoA-I based therapy in restoring cardiac metabolic inflexibility in type 2 diabetes/obese state. In 2020, they became a Project Manager Preclinical at Cantargia AB.

Caitríona Grönberg obtained their Bachelor's Degree in Biotechnology from the Swedish University of Agricultural Sciences (SLU) in 2007, after having started their studies in 2004. Caitríona then continued their education at SLU, earning their Master's Degree in Biotechnology in 2009.